Centralized intestinal organoid generation is a feasible and safe approach for personalized medicine as demonstrated in the HIT-CF Europe Organoid Study

This publication has 13 references indexed in Scilit:

• Protocol for Application, Standardization and Validation of the Forskolin-Induced Swelling Assay in Cystic Fibrosis Human Colon Organoids
  STAR Protocols, 2020
• Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis
  Cell Reports, 2019
• A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening
  Cell Stem Cell, 2018
• A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
  Cell, 2018
• Biobanking: towards increased access of biomaterials in cystic fibrosis. Report on the pre-conference meeting to the 13th ECFS Basic Science Conference, Pisa, 30 March-2 April, 2016
  Journal of Cystic Fibrosis, 2017
• Modeling Development and Disease with Organoids
  Cell, 2016
• Rectal suction biopsy for the diagnosis of Hirschsprung’s disease: a systematic review of diagnostic accuracy and complications
  Pediatric Surgery International, 2015
• Efficacy response in CF patients treated with ivacaftor: Post-hoc analysis
  Pediatric Pulmonology, 2015
• A functional CFTR assay using primary cystic fibrosis intestinal organoids
  Nature Medicine, 2013
• Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
  Nature, 2009